Takeda Pharmaceutical Li... (TAK)
NYSE: TAK
· Real-Time Price · USD
14.98
0.18 (1.22%)
At close: Aug 15, 2025, 3:02 PM
Takeda Pharmaceutical Balance Sheet Statement
Financials in JPY. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Cash & Equivalents | 385.11B | 494.13B | 859.01B | 804.27B | 457.8B | 288.36B | 318.05B | 316.38B | 533.53B | 685.14B | 798.14B | 645.99B | 849.7B | 724.34B | 607.88B | 654.92B |
Short-Term Investments | n/a | n/a | 47.2B | 53.39B | 15.09B | 29.05B | 15.76B | 52.23B | 20.17B | 41.47B | 31.93B | 18.54B | 25.3B | 27.55B | 25.74B | 29.93B |
Long-Term Investments | 10.8B | 12.69B | 277.31B | 447.18B | 430.61B | 372.92B | 416.36B | 393.53B | 378.86B | 369.47B | 425.77B | 381.61B | 330.13B | 334.81B | 352.09B | 374.66B |
Other Long-Term Assets | 792.15B | 847.94B | 85.02B | 106.1B | 51.21B | 54.7B | 59.67B | 60.14B | 63.33B | 66.77B | 80.7B | 84.68B | 82.61B | 79.64B | 94.29B | 95.02B |
Receivables | 709.47B | 711.42B | 721.06B | 772.37B | 697.61B | 743.08B | 788.07B | 825.48B | 681.69B | 779.87B | 800.54B | 794.09B | 724.38B | 756.12B | 887.29B | 858.96B |
Inventory | 1,217.3B | 1,246.4B | 1,206.4B | 1,276.7B | 1,209.9B | 1,169.6B | 1,155.9B | 1,083.4B | 986.46B | 927.29B | 953.45B | 927.51B | 853.17B | 811.32B | 783.48B | 779.15B |
Other Current Assets | 209.26B | 302.32B | 220.31B | 254.15B | 193.3B | 227.75B | 200.08B | 246.78B | 302.54B | 203.65B | 193.49B | 181.92B | 273.26B | 186.11B | 177.7B | 183.43B |
Total Current Assets | 2,521.2B | 2,754.3B | 3,054B | 3,107.5B | 2,558.6B | 2,428.8B | 2,462.1B | 2,472B | 2,398B | 2,595.9B | 2,745.6B | 2,549.5B | 2,593.6B | 2,477.9B | 2,456.4B | 2,476.5B |
Property-Plant & Equipment | 1,968.2B | 2,017.8B | 1,887.6B | 2,085.4B | 1,989.8B | 1,841.5B | 1,894.1B | 1,795.3B | 1,691.2B | 1,656.4B | 1,760.3B | 1,705.4B | 1,582.8B | 1,493.6B | 1,459.9B | 1,452.2B |
Goodwill & Intangibles | 8,956B | 9,474.2B | 8,930.7B | 10,099.9B | 9,684.8B | 9,208.3B | 9,703.4B | 9,696.2B | 9,060.4B | 8,456.7B | 9,181.7B | 8,958.7B | 8,226.3B | 7,959.9B | 7,862B | 7,915.4B |
Total Long-Term Assets | 11,727.2B | 12,352.6B | 11,519B | 13,120.2B | 12,550.2B | 11,794.1B | 12,409.8B | 12,320.7B | 11,559.8B | 10,908.8B | 11,843.2B | 11,515.9B | 10,584.4B | 10,220.6B | 10,103.9B | 10,180.8B |
Total Assets | 14,248.3B | 15,106.8B | 14,573B | 16,227.7B | 15,108.8B | 14,222.9B | 14,871.9B | 14,792.7B | 13,957.8B | 13,504.7B | 14,588.8B | 14,065.4B | 13,178B | 12,698.5B | 12,560.3B | 12,657.2B |
Account Payables | 475.54B | 460.18B | 413.33B | 468.88B | 319.95B | 483.67B | 421.08B | 440.92B | 75.08B | 381.11B | 388.62B | 424.36B | 295.93B | 351.19B | 336.6B | 320.64B |
Deferred Revenue | n/a | n/a | n/a | 162.2B | 109.91B | 594.91B | 787.88B | 770.53B | 740.74B | 661.97B | 674.31B | 714.36B | 644.42B | 606.92B | 603.14B | 611.23B |
Short-Term Debt | 548.94B | 135.47B | 624.1B | 438.74B | 367.25B | 370.29B | 274.84B | 416.86B | 339.6B | 372.02B | 568.23B | 281.9B | 203.99B | 122.94B | 214.89B | 24.27B |
Other Current Liabilities | 1,482B | 1,502.3B | 1,208.4B | 1,395.4B | 1,516B | 833.3B | 883.82B | 873.43B | 1,775.3B | 821.71B | 760.57B | 746.33B | 1,591.9B | 728.21B | 764.12B | 750.64B |
Total Current Liabilities | 2,506.5B | 2,098B | 2,387.2B | 2,465.2B | 2,313.1B | 2,282.2B | 2,367.6B | 2,501.7B | 2,481.9B | 2,236.8B | 2,391.7B | 2,166.9B | 2,145.7B | 1,809.3B | 1,918.8B | 1,706.8B |
Long-Term Debt | 3,966.3B | 4,704.7B | 4,427.1B | 5,042.2B | 4,476.5B | 4,293.9B | 4,404.4B | 4,330.3B | 4,042.7B | 3,914.9B | 4,168.4B | 4,320.4B | 4,141.4B | 4,231.9B | 4,016.5B | 4,381.6B |
Other Long-Term Liabilities | 288.62B | 293.83B | 790.46B | 249.11B | 377.98B | 72.47B | 71.36B | 72.61B | 179.93B | 66.7B | 70.3B | 72.82B | 124.8B | 532.18B | 523.73B | 555.31B |
Total Long-Term Liabilities | 4,805.8B | 5,589.7B | 5,264.2B | 5,963.2B | 5,521.7B | 5,198.2B | 5,433.2B | 5,369.3B | 5,121.1B | 5,091.4B | 5,483.6B | 5,581.1B | 5,348.8B | 5,557.4B | 5,317.2B | 5,711.8B |
Total Liabilities | 7,312.4B | 7,687.7B | 7,651.4B | 8,428.5B | 7,834.8B | 7,480.3B | 7,800.9B | 7,871.1B | 7,603.1B | 7,328.2B | 7,875.4B | 7,748B | 7,494.5B | 7,366.7B | 7,235.9B | 7,418.6B |
Total Debt | 5,066.2B | 5,431.3B | 5,051.2B | 5,481B | 4,843.8B | 4,664.2B | 4,679.2B | 4,747.1B | 4,382.3B | 4,286.9B | 4,736.6B | 4,602.3B | 4,345.4B | 4,354.9B | 4,231.4B | 4,405.9B |
Common Stock | 1,694.7B | 1,694.7B | 1,694.7B | 1,676.6B | 1,676.6B | 1,676.5B | 1,676.5B | 1,676.4B | 1,676.3B | 1,676.3B | 1,676.3B | 1,676.3B | 1,676.3B | 1,676.3B | 1,676.3B | 1,669.1B |
Retained Earnings | 1,187.6B | 1,290.9B | 1,431.7B | 1,338.2B | 1,391.2B | 1,396.8B | 1,446B | 1,490.1B | 1,541.1B | 1,507.7B | 1,530.2B | 1,459.8B | 1,479.7B | 1,466.9B | 1,551.2B | 1,503.8B |
Comprehensive Income | 2,351.9B | 2,701.5B | 2,081.1B | 3,083.7B | 2,509.3B | 1,989.7B | 2,288B | 2,112.9B | 1,508.1B | 1,380.2B | 1,911.2B | 1,602.6B | 934.17B | 584.27B | 451.07B | 425.16B |
Shareholders Equity | 6,935.1B | 7,418.3B | 6,920.8B | 7,798.4B | 7,273.3B | 6,741.9B | 7,070.4B | 6,921.1B | 6,354.1B | 6,176B | 6,712.9B | 6,316.8B | 5,683B | 5,331.3B | 5,323.9B | 5,238.3B |
Total Investments | 10.8B | 12.69B | 324.51B | 447.18B | 430.61B | 401.96B | 432.12B | 100.42B | 399.03B | 410.94B | 457.7B | 97.09B | 96.58B | 104.51B | 115.25B | 404.59B |